Telormedix Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 7

Employees

  • Latest Deal Type
  • M&A

Telormedix General Information

Description

Developer of biopharmaceutical drugs intended to treat cancer and infectious diseases. The company's drugs are developed with a new formulation of a clinically active small molecule compound with a known and favorable safety profile and a specific immunotherapeutic target, enabling cancer patients to get more advanced treatment with a better medical outcome.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Via della Posta 10
  • 6934 Bioggio
  • Switzerland
Primary Industry
Pharmaceuticals
Acquirer
Vertical(s)
Corporate Office
  • Via della Posta 10
  • 6934 Bioggio
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Telormedix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Merger/Acquisition 01-Jan-2015 Completed Generating Revenue
11. Later Stage VC (Series B) 02-Dec-2013 Completed Generating Revenue
10. Grant 07-Aug-2013 Completed Generating Revenue
9. Grant 01-Dec-2012 Completed Startup
8. Grant 04-Jun-2012 Completed Startup
7. Grant 26-Mar-2012 Completed Startup
6. Later Stage VC 10-Jan-2012 Completed Startup
5. Grant 01-Jan-2012 Completed Startup
4. Grant 05-Sep-2011 $1.05M $19M Completed Startup
3. Secondary Transaction - Private 01-Jan-2011 $19M Completed Startup
To view Telormedix’s complete valuation and funding history, request access »

Telormedix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biopharmaceutical drugs intended to treat cancer and infectious diseases. The company's drugs are developed
Pharmaceuticals
Bioggio, Switzerland
7 As of 2016

Vienna, Austria
 

Karachi, Pakistan
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Telormedix Competitors (15)

One of Telormedix’s 15 competitors is Pfizer (Vienna), a Corporation company based in Vienna, Austria.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pfizer (Vienna) Corporation Vienna, Austria
Pfizer Pakistan Corporation Karachi, Pakistan
Gesynta Pharma Venture Capital-Backed Stockholm, Sweden
Ability Pharma Private Equity-Backed Cerdanyola, Spain
Aytu Biopharma Formerly VC-backed Denver, CO
You’re viewing 5 of 15 competitors. Get the full list »

Telormedix Patents

Telormedix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2015104030-A1 Pharmaceutical compositions comprising imiquimod for use in the treatment of carcinoma in situ of the bladder Inactive 10-Jan-2014
WO-2015104219-A1 Pharmaceutical compositions comprising imiquimod for use in the treatment of carcinoma in situ of the bladder Inactive 10-Jan-2014
WO-2015036044-A1 Cationic lipid vehicles for delivery of tlr7 agonists for specific targeting of human cd14+ monocytes in whole blood Inactive 13-Sep-2013
WO-2014053222-A1 Phospholipid drug analogs Inactive 01-Oct-2012
US-20120083473-A1 Treatment of conditions by toll-like receptor modulators Inactive 21-Sep-2010 A61K31/52
To view Telormedix’s complete patent history, request access »

Telormedix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Telormedix Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aravis Growth/Expansion Minority
Assicurazioni Generali Corporation Minority
BSI Investment Bank Minority
Nextech Invest Venture Capital Minority
ProQuest Investments Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Telormedix Investments (1)

Telormedix’s most recent deal was a Later Stage VC with Urogen Pharma for . The deal was made on 22-May-2013.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Urogen Pharma 22-May-2013 Later Stage VC Drug Delivery
To view Telormedix’s complete investments history, request access »

Telormedix FAQs

  • When was Telormedix founded?

    Telormedix was founded in 2007.

  • Where is Telormedix headquartered?

    Telormedix is headquartered in Bioggio, Switzerland.

  • What is the size of Telormedix?

    Telormedix has 7 total employees.

  • What industry is Telormedix in?

    Telormedix’s primary industry is Pharmaceuticals.

  • Is Telormedix a private or public company?

    Telormedix is a Private company.

  • What is Telormedix’s current revenue?

    The current revenue for Telormedix is .

  • How much funding has Telormedix raised over time?

    Telormedix has raised $33.4M.

  • Who are Telormedix’s investors?

    Aravis, Assicurazioni Generali, BSI, Nextech Invest, and ProQuest Investments are 5 of 6 investors who have invested in Telormedix.

  • Who are Telormedix’s competitors?

    Pfizer (Vienna), Pfizer Pakistan, Gesynta Pharma, Ability Pharma, and Aytu Biopharma are some of the 15 competitors of Telormedix.

  • When was Telormedix acquired?

    Telormedix was acquired on 01-Jan-2015.

  • Who acquired Telormedix?

    Telormedix was acquired by Urogen Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process